Gheorghe Doros, PhD
Professor
Boston University School of Public Health
Dept of Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest



Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in Statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Dr. Doros’s research on methodological approaches and strategies has been concentrated in the area of clinical trials, more specifically on Bayesian approaches to clinical trials and the area of placebo response in clinical trials. The outcome of his work has been a corner stone in developing a host of collaborations with outstanding faculty, clinicians, and researchers at the Boston University Medical Campus and at other institutions. These productive collaborations have resulted in several federally funded grants. Dr. Doros authored and co-authored many peer-reviewed publications of original and innovative research which has had a major impact on the field. On the majority of publications, Dr. Doros is the lead statistician author. He demonstrated continuing record of multidisciplinary research that has had a major impact on the rapidly changing field. His publications on clinical trials; most proposing the design, analysis and new methodologies or of significant contributions to this field.

Dr. Doros is a very active and effective teacher and mentor in the department of Biostatistics. His teaching philosophy is to pursue an active approach to learning and to engage students to think critically. He taught core and elective courses for Master and PhD-level courses. The excellent course evaluations he received attests to his ability in engaging students in active learning. Dr. Doros has been awarded the excellence in teaching three times in three years.

On a national level, Dr. Doros has served as an Associate Editor for the BioMed Central’s journal Trials and as a reviewer for a number of academic journals. He served as a member of the merit review subcommittee for Epidemiology of the Department of Veteran Affairs and a member NHLBI-Ancillary Studies in Clinical Trials between 2012 and 2014. He has served as a statistical expert on a number of Independent Data Monitoring Committee(IDMC) for clinical trials and clinical programs. He served or seves as a senior consultant on multicenter trials and/or programs for the following organizations Pfizer, Takeda, Avanir, Sarepta and Children's Hospital.

Boston Medical Center



2008-2010 Boston University School of Public Health: Excellence in Teaching Award


GHEORGHE DOROS, PHD: STATISTICAL RESEARCH IN CLINICAL TRIALS (BAIM INSTITUTE FOR CLINICAL RESEARCH)
09/01/2017 - 08/31/2018 (PI)
Baim Institute for Clinical Research

PERSONNEL AGREEMENT FOR RESEARCH SERVICES OF GHEORGHE DOROS
05/01/2016 - 08/31/2018 (PI)
VA Boston Healthcare System

GHEORGHE DOROS, PHD (FACULTY): STATISTICAL RESEARCH IN CLINICAL TRIALS (HARVARD CLINICAL RESEARCH INSTITUTE)
09/01/2016 - 08/31/2017 (PI)
Harvard Clinical Research Institute

PERSONNEL AGREEMENT FOR RESEARCH SERVICES OF GHEORGHE DOROS
06/01/2012 - 02/28/2016 (PI)
VA Boston Healthcare System

PERSONNEL AGREEMENT FOR RESEARCH SERVICES OF GHEORGHE DOROS
07/01/2012 - 05/31/2013 (PI)
VA Boston Healthcare System

PERSONNEL AGREEMENT FOR RESEARCH SERVICES OF GHEORGHE DOROS
08/01/2009 - 03/31/2012 (PI)
VA Boston Healthcare System

PERSONNEL AGREEMENT FOR RESEARCH SERVICES OF GHEORGHE DOROS
06/01/2008 - 03/31/2012 (PI)
VA Boston Healthcare System

Lower Extremity Muscle Power and Function in the Elderly
06/15/2005 - 05/31/2010 (PI)
Tufts University NIH NIA




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Yawn BP, Israel E, Wechsler ME, Pace W, Madison S, Manning B, Doros G, Fuhlbrigge A. The asthma Symptom Free Days Questionnaire: how reliable are patient responses? J Asthma. 2018 Oct 26; 1-9. PMID: 30365368.
     
  2. Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V. Development and validation of a survival staging system incorporating BNP in patients with light chain (AL) amyloidosis. Blood. 2018 Oct 17.View Related Profiles. PMID: 30333122.
     
  3. Tan TW, Siracuse JJ, Brooke BS, Baril DT, Woo K, Rybin D, Doros G, Farber A. Comparison of one-stage and two-stage upper arm brachiobasilic arteriovenous fistula in the Vascular Quality Initiative. J Vasc Surg. 2018 Oct 06.View Related Profiles. PMID: 30301685.
     
  4. Roguin A, Kandzari DE, Marcusohn E, Koolen JJ, Doros G, Massaro JM, Garcia-Garcia HM, Bennett J, Gharib EG, Cutlip DE, Waksman R. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. Circ Cardiovasc Interv. 2018 Oct; 11(10):e007331.View Related Profiles. PMID: 30354631.
     
  5. Kandzari DE, Koolen JJ, Doros G, Massaro JJ, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R. Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year Results. J Am Coll Cardiol. 2018 Sep 19. PMID: 30257191.
     
  6. Reynolds MR, Zheng Q, Doros G. Laser balloon ablation for AF: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2018 Oct; 29(10):1363-1370. PMID: 30016008.
     
  7. Traish AM, Krakowsky Y, Doros G, Morgentaler A. Do 5a-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results. Sex Med Rev. 2018 Aug 08.View Related Profiles. PMID: 30098986.
     
  8. Grossman NL, Doros GD, Fandino N, Fuhlbrigge AL, Pace WD, Wechsler ME, Yawn BP, Israel E. Susceptibility to Exacerbations in Black Adults with Asthma. J Asthma. 2018 Jul 04; 1-20. PMID: 29969928.
     
  9. Siracuse JJ, Paracha M, Farber A, Rybin D, Doros G, Tseng J, McAneny D, Sachs T. Never events after hepatopancreatobiliary operations. Am J Surg. 2018 Jun 30.View Related Profiles. PMID: 30146274.
     
  10. Komshian S, Farber A, Patel VI, Goodney PP, Schermerhorn ML, Blazick EA, Jones DW, Rybin D, Doros G, Siracuse JJ. Patients with end-stage renal disease have poor outcomes after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2018 Jun 23.View Related Profiles. PMID: 29945838.
     
Showing 10 of 274 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 270 publications over 16 distinct years, with a maximum of 41 publications in 2014

YearPublications
20031
20041
20051
20063
20077
20084
200914
201014
201115
20129
201321
201441
201539
201628
201739
201833
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Doros's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department